The Pan-Immune-Inflammation Value (PIV) predicts major adverse cardiovascular events in elderly patients undergoing percutaneous coronary intervention: a real-world study

Scritto il 04/03/2026
da Junying Duan

No abstract

BMC Cardiovasc Disord. 2026 Mar 4. doi: 10.1186/s12872-026-05679-y. Online ahead of print.

NO ABSTRACT

PMID:41781875 | DOI:10.1186/s12872-026-05679-y